Specialities
MedTalks TV
.webp)
.webp)
.webp)
.webp)
Recent Medbytes
Issued by Padma Awardee Doctors GroupIndia is experiencing extremely poor air quality across several regions, particularly Delhi–NCR & Mumbai. Air pollution has become a significant public healt... Read More
.png)
Mounjaro® (tirzepatide) is a once-weekly injectable medication, FDA-approved for type 2 diabetes, that helps improve blood sugar control. While primarily indicated for diabetes, Mounjaro is also p... Read More
.png)
Key Similarities Both treat type 2 diabetes and promote weight loss. These are once-weekly injections: mounjaro (tirzepatide) and semaglutide (Ozempic). Both lower a... Read More
.png)
Mounjaro is approved for type 2 diabetes, where it helps control blood sugar and also supports weight loss in many patients. Starting and Titration Providers usually begin with a low dose to li... Read More
.png)
Price and AccessThe cost of Mounjaro® (tirzepatide) varies by country, insurance coverage, and pharmacy availability. In the U.S., it can be expensive without insurance, though some plans may cove... Read More
Meet Our Faculty
DR.KK AGGARWAL
Cardiology
DR.SANJAY KALRA
Diabetes & Endocrinology
DR.SURYA KANT TRIPATHI
Pulmonary Medicine
DR.SHASHANK JOSHI
Cardiology
DR.RAJESH MALHOTRA
Orthopedics
DR.PRAMOD KUMAR JULKA
Oncology
DR.NAGESHWAR REDDY
Gastroenterology
DR.ANIL GANJOO
Dermatology
DR.KK AGGARWAL
Cardiology
DR.SANTHOSH S
Nephrology
DR.ALKA MAKWANA
Dermatology
DR.KHYATI VASAVADA
Dermatology
DR.MONAL SHAH
Dermatology
DR.BHARADWAJ BATCHU
Nephrology
